Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults

Postgraduate Medicine

Volumn 121, Issue 6, 2009, Pages 101-105

  Rehm, Susan J ^a,b   Farley, Monica M ^c   File Jr , Thomas M ^a,d   Hall, William J ^e   Hopkins, Robert ^f   Levine, Orin S ^g,h   Nichol, Kristin L ⁱ   Nuorti, Pekka ^j,k   Zimmerman, Richard K ^l   Schaffner, William ^a,m  

^a National Foundation for Infectious Diseases   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g EMORY UNIVERSITY   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^l UNIVERSITY OF PITTSBURGH   (United States)

^m VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Community acquired pneumonia; H1N1 influenza; Invasive pneumococcal disease; Pneumococcal disease; PPSV23

Indexed keywords

CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

AGING; ANTIBIOTIC RESISTANCE; BACTEREMIA; CHRONIC DISEASE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFECTION RISK; MORBIDITY; MORTALITY; PATIENT IDENTIFICATION; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; REVIEW; RISK FACTOR; SECONDARY INFECTION; SMOKING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; ADULT; AGED; ARTICLE; EPIDEMIC; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; PATIENT ATTITUDE; UTILIZATION REVIEW;

ADULT; AGED; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; UNITED STATES; VACCINATION;

EID: 73949083237     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.11.2069     Document Type: Review

References (32)

1. Whitney CG, Farley MM, Hadler J, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737-1746.
2. Lexau CA, Lynfield R, Danila R, et al; Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294(16):2043-2051.
3. Shah SS, Ratner AJ. Trends in invasive pneumococcal disease - associated hospitalizations. Clin Infect Dis. 2006;42(1):e1-e5.
4. Hsu HE, Shun KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244-256.
5. Active Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network: Streptococcus pneumoniae, 2007. Centers for Disease Control and Prevention. 2008. http://www.cdc.gov/ncidod/dbmd/abcs/survreports/ spneu07.pdf. Accessed October 2, 2009.
6. Active Bacterial Core Surveillance (ABCs) Report: Emerging Infections Program Network: Streptococcus pneumoniae, provisional-2008. Centers for Disease Control and Prevention. 2009. http://www.cdc.gov/ncidod/dbmd/abcs/ survreports/spneu08.pdf. Accessed October 2, 2009.
7. World Health Organization. 23-valent pneumococcal polysaccharide vaccine: WHO position paper. Weekly Epidemiological Record. 2008;83(42):373-384.
8. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Engl J Med. 2000;342(10):681-689.
9. Centers for Disease Control and Prevention. Recommended adult immunization schedule - United States, MMWR. 2009;57(53):Q1-Q4.
10. National Center for Health Statistics. Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. Bethesda, MD: Centers for Disease Control and Prevention. July 2009.
11. Centers for Disease Control and Prevention. Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak. July 9, 2009. http://www.cdc.gov/h1n1flu/guidance/ppsv-h1n1.htm. Accessed October 2, 2009.
12. Administration on Aging, US Department of Health and Human Services. A Profile of Older Americans: 2008. www.aoa.gov/AoAroot/Aging-Statistics/Profile/ 2008/docs/2008profile.pdf. Accessed October 2, 2009.
13. US Census Bureau News. Census Bureau Reports World's Older Population Projected to Triple by 2050. Press Release, June 23, 2009. www.census.gov/Press- Release/www/releases/archives/international-population/013882.html. Accessed October 2, 2009.
14. Boyd CM, Ritchie CS, Tipton EF, et al. From bedside to bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res. 2008;20(3):181-188.
15. Fry AM, Shay DK, Holman RC, et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA. 2005;294(21):2712-2719.
16. File TM, Tan JS. Pneumonia in older adults: reversing the trend. JAMA. 2005;294(21):2760-2763.
17. Mandell LA, Winderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
18. Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults - United States, 2007. MMWR. 2008;57(45):1221-1226.
19. File TM. Community-acquired pneumonia. Lancet. 2003;362(9400):1991-2001.
20. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642-1650.
21. Tsai JC, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis. 2008;46(11):1664-1672.
22. Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurology. 2006;5(2):123-129.
23. Ogilvie I, El Khoury AE, Cui Y, et al. Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions. Vaccine. 2009;27(36):4891-4904.
24. Gorina Y, Kelly T, Lubiz J, Hines Z. Trends in influenza and pneumonia among older persons in the United States. Aging Trends. 2008;8:1-11.
25. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT. Hospitalized community-acquired pneumonia in the elderly. Am J Respir Crit Care Med. 2002;165(6):766-772.
26. Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007;45(2):158-165.
27. Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8(12):785-795.
28. US Department of Health and Human Services. Healthy People 2010. www.healthypeople.gov. Accessed October 2, 2009.
29. National Center for Health Statistics, Centers for Disease Control and Prevention. National Center for Health Statistics National Health Interview Survey, 2007. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2008.
30. Kyaw MH, Greene CM, Schaffner W, et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Adults with invasive pneumococcal disease: missed opportunities for vaccination. Am J Prev Med. 2006;31(4):286-292.
31. Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2008(1):CD000422.
32. Centers for Disease Control and Prevention (CDC). Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged < 65 years at high risk. MMWR. 2005;54(RR-5):1-11.